The U.S. peripheral vascular devices and accessories sector is entering a significant growth phase driven by clinical demand, strategic consolidation, and rapid technological innovation. Healthcare providers are increasingly focusing on minimally invasive vascular interventions to treat complex arterial and venous conditions efficiently, reducing hospital stays and procedural risks.

A key factor fueling this growth is the rising prevalence of Peripheral Artery Disease. Aging demographics, sedentary lifestyles, and increasing rates of diabetes and obesity have created sustained demand for advanced devices, including drug-coated balloons, stents, atherectomy systems, and thrombectomy solutions.

The U.S. peripheral vascular devices and accessories market was valued at USD 4.1 billion in 2025 and is projected to reach USD 6.2 billion by 2033, representing a compound annual growth rate of 5.1% between 2026 and 2033. This growth reflects not only increased procedural volumes but also the adoption of premium technologies that improve patient outcomes.

Innovation and Consolidation Shaping Competitive Advantage

A defining trend in this market is the intersection of technological innovation with strategic acquisitions. Leading medical technology companies are expanding their vascular portfolios to provide comprehensive solutions covering diagnosis, intervention, and post-procedure care.

Recent acquisitions emphasize thrombectomy and clot-management devices, particularly for treating deep vein thrombosis and pulmonary embolism, which require rapid intervention.

Innovation is also moving toward precision and efficiency. Bioresorbable scaffolds, next-generation drug-coated balloons, and advanced imaging-guided systems are redefining procedural standards. Robotics and AI-assisted navigation are further enhancing the precision of complex vascular procedures, while minimizing operator fatigue.

Additionally, a shift toward outpatient and ambulatory care settings is reshaping device requirements. Smaller, user-friendly devices and a wide array of accessories—guidewires, catheters, and vascular closure systems—are becoming essential to streamline procedures and improve clinical outcomes.

Key U.S. Peripheral Vascular Devices and Accessories Companies

The competitive landscape includes both global leaders and specialized innovators who continuously invest in R&D to maintain differentiation.

• Abbott
• Terumo Corporation
• Nipro
• Medtronic
• Boston Scientific Corporation
• Cordis
• Koninklijke Philips N.V.
• AngioDynamics
• ASAHI INTECC CO., LTD.

Companies such as Medtronic, Boston Scientific Corporation, and Abbott continue to lead with diversified product pipelines backed by strong clinical evidence. Meanwhile, specialized firms like Terumo Corporation and ASAHI INTECC CO., LTD. are gaining prominence with innovative guidewire and catheter solutions.

Market Outlook and Opportunities

Looking forward, the U.S. market is poised to remain a global leader in both adoption and innovation of peripheral vascular technologies. Growth opportunities will focus on areas that balance clinical effectiveness with economic value.

High-potential segments include:

• Thrombectomy and clot-removal systems
• Drug-coated and bioresorbable devices
• Advanced imaging-integrated intervention platforms
• Accessories that enhance procedural efficiency

Regulatory emphasis on clinical outcomes and standardized care pathways is encouraging providers to adopt devices with proven long-term benefits. Companies that align innovation with usability, cost efficiency, and positive patient outcomes are likely to emerge as market leaders in an expanding and competitive landscape.